Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Helga Rothe & Hubert Kolb. (1998) The APC1 Concept of Type I Diabetes. Autoimmunity 27:3, pages 179-184.
Read now
Read now
Articles from other publishers (29)
Bart O. Roep, Sofia Thomaidou, René van Tienhoven & Arnaud Zaldumbide. (2020) Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?). Nature Reviews Endocrinology.
Crossref
Crossref
Dana M. PreviteJon D. Piganelli. (2018)
Reactive Oxygen Species and Their Implications on CD4
+
T Cells in Type 1 Diabetes
. Antioxidants & Redox Signaling 29:14, pages 1399-1414.
Crossref
Crossref
Gina M. Coudriet, Dana M. Previte & Jon D. Piganelli. 2016. Redox-Active Therapeutics. Redox-Active Therapeutics
647
667
.
Jaime Haidet, Vincenza Cifarelli, Xuehui Geng, Massimo Trucco & Patrizia Luppi. 2012. Diabetes & C-Peptide. Diabetes & C-Peptide
111
127
.
Sergio A. Lira, Abel Viejo‐Borbolla, Limin Shang & Andrea P. Martin. 2009. Chemokines, Part A. Chemokines, Part A
193
207
.
Andrea P. Martin, Jennifer M. Alexander-Brett, Claudia Canasto-Chibuque, Alexandre Garin, Jonathan S. Bromberg, Daved H. Fremont & Sergio A. Lira. (2007) The Chemokine Binding Protein M3 Prevents Diabetes Induced by Multiple Low Doses of Streptozotocin. The Journal of Immunology 178:7, pages 4623-4631.
Crossref
Crossref
Daniel R. Johnson, Jason C. O'Connor, Ansuman Satpathy & Gregory G. Freund. 2006. Interleukins. Interleukins
405
441
.
Thorsten Zacher, Ina Knerr, Wolfgang Rascher, Joachim R. Kalden & Ralf Wassmuth. (2002) Characterization of Monocyte-Derived Dendritic Cells in Recent-Onset Diabetes Mellitus Type 1. Clinical Immunology 105:1, pages 17-24.
Crossref
Crossref
Lorenzo Piemonti, Biagio Eugenio Leone, Rita Nano, Alessandra Saccani, Paolo Monti, Paola Maffi, Giancarlo Bianchi, Antonio Sica, Giuseppe Peri, Raffaella Melzi, Luca Aldrighetti, Antonio Secchi, Valerio Di Carlo, Paola Allavena & Federico Bertuzzi. (2002) Human Pancreatic Islets Produce and Secrete MCP-1/CCL2: Relevance in Human Islet Transplantation. Diabetes 51:1, pages 55-65.
Crossref
Crossref
J.B. Classen & D.C. Classen. (2001) Vaccines and the risk of insulin-dependent diabetes (IDDM): potential mechanism of action. Medical Hypotheses 57:5, pages 532-538.
Crossref
Crossref
Sabine Bieg, William Simonson, Kristian Ellefsen & ???ke Lernmark. (2000) Rel B Is an Early Marker of Autoimmune Islet Inflammation in the BioBreeding (BB) Rat. Pancreas 20:1, pages 47-54.
Crossref
Crossref
Janusz My?liwiec, Adam Kr?towski, Maciej Kinalski & Ida Kinalska. (1999) CD11a Expression and soluble ICAM-1 levels in peripheral blood in high-risk and overt type 1 diabetes subjects. Immunology Letters 70:1, pages 69-72.
Crossref
Crossref
Abha Saini, Yue J. Liu, David J. Cohen & Boon S. Ooi. (1996) Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1. Metabolism 45:9, pages 1125-1129.
Crossref
Crossref
T. Mandrup-Poulsen. (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:9, pages 1005-1029.
Crossref
Crossref
H. Rothe, V. Burkart, A. Faust & H. Kolb. (1996) Interleukin-12 gene expression is associated with rapid development of diabetes mellitus in non-obese diabetic mice. Diabetologia 39:1, pages 119-122.
Crossref
Crossref
Yue J. Liu, Abha Saini, David J. Cohen & Boon S. Ooi. (1995) Modulation of macrophage proliferation by hyperglycemia. Molecular and Cellular Endocrinology 114:1-2, pages 187-192.
Crossref
Crossref
F. A. Gries, H. Kolb & T. Koschinsky. 1995. Oxidative Stress and Aging. Oxidative Stress and Aging
191
201
.
A. J. Davies, A. J. Bone, T. J. Wilkin, D. R. Cole & H. Rokos. (1994) Serum biopterin — a novel marker for immune activation during pre-diabetes in the BB rat. Diabetologia 37:5, pages 466-470.
Crossref
Crossref
Thomas Mandrup-Poulsen, Urs Zumsteg, Jesper Reimers, Flemming Pociot, Lise Mørch, Steffen Helqvist, Charles A. Dinarello & Jørn Nerup. (1993) Involvement of interleukin 1 and interleukin 1 antagonist in pancreatic β-cell destruction in insulin-dependent diabetes mellitus. Cytokine 5:3, pages 185-191.
Crossref
Crossref
Volker Burkart, Yoichiro Imai, Boris Kallmann & Hubert Kolb. (2001) Cyclosporin A protects pancreatic islet cells from nitric oxide‐dependent macrophage cytotoxicity. FEBS Letters 313:1, pages 56-58.
Crossref
Crossref
Daniël Pipeleers & Zhidong Ling. (1992) Pancreatic beta cells in insulin-dependent diabetes. Diabetes / Metabolism Reviews 8:3, pages 209-227.
Crossref
Crossref
T.E. Mandel. 1992. Molecular Immunology. Molecular Immunology
157
196
.
CLAUDE C.A. BERNARD, TOM E. MANDEL & IAN R. MACKAY. 1992. The Autoimmune Diseases II. The Autoimmune Diseases II
47
106
.
Jürgen Zielasek & Hubert Kolb. (1992) Ganglioside therapy of type I diabetes: Enhancement of hyperglycemia in the low dose streptozotocin model. Life Sciences 51:1, pages 49-52.
Crossref
Crossref
Leonard C. Harrison. (1991) Transgenic approaches to understanding the role of MHC genes in insulin dependent diabetes mellitus I. Immune and non-immune mechanisms of ? cell destruction. Bailli?re's Clinical Endocrinology and Metabolism 5:3, pages 439-448.
Crossref
Crossref
J. MØLVIG, F. POCIOT, L. BÆK, H. WORSAAE, L. DALL WOGENSEN, P. CHRISTENSEN, L. STAUB‐NIELSEN, T. MANDRUP‐POULSEN, K. MANOGUE & J. NERUP. (2006) Monocyte Function in IDDM Patients and Healthy Individuals. Scandinavian Journal of Immunology 32:3, pages 297-311.
Crossref
Crossref
J. Allison, L. C. Harrison, I. L. Campbell & J. F. A. P. Miller. 1990. The Role of Viruses and the Immune System in Diabetes Mellitus. The Role of Viruses and the Immune System in Diabetes Mellitus
121
135
.
H. Kolb & V. Kolb-Bachofen. 1990. The Molecular Biology of Autoimmune Disease. The Molecular Biology of Autoimmune Disease
313
323
.
R. Mirakian, A. Ciampolillo, U. Deuss, A. Miyazaki & G. F. Bottazzo. 1990. The Role of Micro-organisms in Non-infectious Diseases. The Role of Micro-organisms in Non-infectious Diseases
131
154
.